TBCK Syndrome | CHOP Research Institute
 

TBCK Syndrome

Published on
Nov 17, 2023
Kristen Navarro, PhD, discusses her definition of diversity in science, her research on rare diseases, and her cat, Caramel.
Published on
Oct 26, 2023
Xilma Ortiz-Gonzalez, MD, PhD, guest speaker at the 2023 TBCK Conference, shares new research for a rare, progressive, neurodegenerative disease.
Published on
Oct 12, 2023
The Featured Research Staff Member for Hispanic Heritage Month is Marco Flores-Mendez, PhD.
Published on
Oct 14, 2022
Read the latest findings and new grants from Children’s Hospital of Philadelphia researchers.

The purpose of this study is to create a biorepository to support our ongoing and future studies on ultra-rare pediatric neurodegenerative disorders.

Published on
Oct 21, 2021
Findings support lysosomal acidification strategies for pediatric neurodegenerative disorders with impaired mitochondrial quality control.

The Ortiz-Gonzalez Lab investigates whether mitochondrial dysfunction is a common, underlying factor in rare pediatric neurodegenerative disorders.

Published on
Jun 18, 2020
Xilma Ortiz-Gonzalez, MD, PhD, a neurogeneticist early in her career, receives a Burroughs Wellcome Fund Career in Medical Sciences Award.

The Bhoj Lab discovers new human disease genes, their mechanisms, and potential targeted therapies. A bedside-to-bench-to-bedside translational lab that brings discoveries back to patients, we are focused on three novel genes that lead to pediatric neurologic dysfunction: TBCK, H3F3A/B, and MAP4K4.

Dr. Bhoj's genetics research aims to discover new human disease genes, their mechanisms, and potential targeted therapies. In addition to ongoing gene discovery efforts, Dr. Bhoj focuses on three novel genes that lead to pediatric neurologic dysfunction: TBC1 domain-containing kinase, Histone 3.3 (H3F3A and H3F3B), and MAP4K4.

E-mail:
bhoje [at] chop.edu